Targeting cellular and microenvironmental multidrug resistance

Protease-Mediated Release of Chemotherapeutics from Mesoporous Silica Nanoparticles to ex Vivo Human and Mouse Lung Tumors

(2015) Sabine H. van Rijt et al.   ACS Nano

MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer

(2015) Xiaoqian Yang et al.   Scientific Reports

Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo

(2013) Huan Meng et al.   ACS Nano

Multidrug resistance: Physiological principles and nanomedical solutions

(2013) Sijumon Kunjachan et al.   ADVANCED DRUG DELIVERY REVIEWS

Enhanced antitumor efficacy by methotrexate conjugated Pluronic mixed micelles against KBv multidrug resistant cancer

(2013) Yanzuo Chen et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation

(2013) T. T. Batchelor et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The tumor microenvironment is a dominant force in multidrug resistance

(2012) Ana Luísa Correia et al.   DRUG RESISTANCE UPDATES

Traceable Multifunctional Micellar Nanocarriers for Cancer-Targeted Co-delivery of MDR-1 siRNA and Doxorubicin

(2011) Xiao-Bing Xiong et al.   ACS Nano

Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes

(2011) Niravkumar R. Patel et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro

(2011) Forrest M. Kievit et al.   JOURNAL OF CONTROLLED RELEASE

Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers

(2008) Elena V. Batrakova et al.   JOURNAL OF CONTROLLED RELEASE